Rasio rega marang bathi Aprea Therapeutics Inc. (APRE)

Aprea Therapeutics, Inc. - logo grafis emiten APRE

Aprea Therapeutics' development of anti-tumor agents is independent of GDP phases and seasonal fluctuations, maintaining high macro-stability. Highly qualified management focuses on precision medicine and the restoration of tumor suppression functions. The market dynamics reflected in the quotes on GURU.Markets show a value of -0.40, while p53 patent protection and strict FDA control create insurmountable barriers for new entrants.

Aprea Therapeutics Inc. (APRE) - Rasio rega marang bathi saka 04.07.2022 nganti 12.11.2026

Rincian metrik komprehensif lan analitis Aprea Therapeutics Inc. (APRE)

- rega lan prakiraan konsensus rega:
Rega saham Aprea|APRE - Bagan rega target
- rincian kapitalisasi pasar:
Nilai pasar Aprea Therapeutics, Inc.|APRE - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- informasi kapitalisasi buku:
Nilai Akuntansi Saham Aprea Therapeutics|APRE - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku aprea.com|APRE - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas Aprea Therapeutics|APRE - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Aprea|APRE - Utang perusahaan|Utang-utang marang nilai buku Aprea Therapeutics, Inc.|APRE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aprea Therapeutics|Likuiditas darurat aprea.com
- indikator bathi lan kelipatan valuasi:
APRE - Bathi resik|Proyeksi bathi resik Aprea Therapeutics|APRE - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi Aprea|APRE - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Aprea Therapeutics, Inc.|APRE - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Aprea Therapeutics|APRE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan aprea.com|APRE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea Therapeutics
Analisis komprehensif perusahaan:APRE (aprea.com)
Sampel barang Aprea Therapeutics

The P/E ratio determines the market value of a single unit of a company's net profit. For Aprea Therapeutics (APRE), which develops DNA repair inhibitors in tumors, this metric reflects market expectations regarding the future commercialization of its drugs. By analyzing the current price-to-earnings valuation, an investor can gauge the premium paid for the biotech's potential. Negative values here signal an R&D investment phase, and the metric allows for an assessment of capital investment risk.

Analisis perusahaan pesaing

Pangali P/E incyte.com|Rasio rega marang bathi HUTCHMED (HCM)|Rasio rega marang bathi NUVB (Nuvation Bio Inc)|Day One Bio - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik MNPR|INBX - Rasio rega marang bathi|Kapitalisasi marang bathi I-Mab|Fennec Pharmaceuticals Inc. (FENC) - Rasio rega marang bathi|Pangali rega marang bathi HRTX|NVCT (Nuvectis) - Pangali P/E|Koefisien rega marang bathi coherus.com (CHRS)|Rasio rega marang bathi Corbus Pharmaceuticals (CRBP)|CRDF - Kapitalisasi marang bathi|Rasio rega marang bathi BeyondSpring BYSI|BioAtla Inc - Rasio rega marang bathi|LIXT - Rasio rega marang bathi|Kapitalisasi marang bathi Citius Pharmaceuticals|CLRB: Pangali P/E|Rasio kapitalisasi marang bathi resik biolinerx.com BLRX|Koefisien rega marang bathi CANF|Kapitalisasi marang bathi Kazia KZIA|Koefisien rega marang bathi SLXN (Silexion Therapeutics Corp)|NCNA (nucana.com) - Nilai perusahaan marang bathi resik|Chimerix, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik CYCC (cyclacel.com)|G1 Pharma - Pangali P/E|Nilai perusahaan marang bathi resik KRON (Kronos Bio Inc)|KTRA: Pangali P/E|Kapitalisasi marang bathi Oncternal Corp (ONCT)|Rasio rega marang bathi Portage Biotech Inc.